ARTA
ZYME icon

A.R.T. Advisors’s Zymeworks ZYME Stock Holding History

A.R.T. Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-44,222
Closed -$2.01M – 1024
2019
Q4 		$2.01M Buy
44,222
+14,800
+50% +$538K 0.1% 293
2019
Q3 		$730K Buy
29,422
+20,300
+223% +$509K 0.04% 700
2019
Q2 		$201K Buy
+9,122
New +$167K 0.01% 1110

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

A.R.T. Advisors's ZYME Position: Q1 2020 in Review

A.R.T. Advisors sold out of Zymeworks (ZYME) in Q1 2020, closing a stake of 44,222 shares — an estimated $2.01M sold.

A.R.T. Advisors first reported a position in ZYME in Q2 2019 and held it in 3 quarters. The position peaked at $2.01M in Q4 2019. 116 funds tracked by Wall St. Rank hold ZYME as of Q1 2020.

  • A.R.T. Advisors reported no remaining Zymeworks position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 44,222 Zymeworks shares in Q1 2020, an estimated $2.01M.
  • A.R.T. Advisors first reported a position in Zymeworks in Q2 2019 and held it in 3 quarters.
  • A.R.T. Advisors's Zymeworks position peaked at $2.01M in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Zymeworks as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.